Orientbio (002630)

Currency in KRW
659
+8(+1.23%)
Closed·
002630 Scorecard
Full Analysis
Suffers from weak gross profit margins
002630 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
649663
52 wk Range
4082,560
Key Statistics
Bid/Ask
659.00 / 660.00
Prev. Close
651
Open
652
Day's Range
649-663
52 wk Range
408-2,560
Volume
939.08K
Average Volume (3m)
3.58M
1-Year Change
29.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002630 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Orientbio Company Profile

ORIENT BIO Inc. operates in the bio-industry in South Korea. It produces laboratory animals; and offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam-si, South Korea.

Compare 002630 to Peers and Sector

Metrics to compare
002630
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.000.080.00
Price/Book
0.0x1.5x2.6x
Price / LTM Sales
0.0x2.5x3.3x
Upside (Analyst Target)
0.0%15.8%40.1%
Fair Value Upside
Unlock−0.3%5.1%Unlock

Earnings

Latest Release
Feb 14, 2023
EPS / Forecast
-107.10 / --
Revenue / Forecast
8.07B / --
EPS Revisions
Last 90 days

002630 Income Statement

FAQ

What Stock Exchange Does Orientbio Trade On?

Orientbio is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Orientbio?

The stock symbol for Orientbio is "002630."

What Is the Orientbio Market Cap?

As of today, Orientbio market cap is 78.14B.

What Is Orientbio's Earnings Per Share (TTM)?

The Orientbio EPS (TTM) is -57.81.

From a Technical Analysis Perspective, Is 002630 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Orientbio Stock Split?

Orientbio has split 9 times.

How Many Employees Does Orientbio Have?

Orientbio has 125 employees.

What is the current trading status of Orientbio (002630)?

As of 17 Aug 2025, Orientbio (002630) is trading at a price of 659.00, with a previous close of 651.00. The stock has fluctuated within a day range of 649.00 to 663.00, while its 52-week range spans from 408.00 to 2,560.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.